Mustang Bio, Inc. - Common Stock, $0.0001 Par Value (MBIO)

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Stock, $0.0001 Par Value
Shares outstanding
52,979,435
Total 13F shares
1,033,145
Share change
+440,675
Total reported value
$1,396,080
Price per share
$1.35
Number of holders
25
Value change
+$579,173
Number of buys
8
Number of sells
7

Institutional Holders of Mustang Bio, Inc. - Common Stock, $0.0001 Par Value (MBIO) as of Q4 2023

As of 31 Dec 2023, Mustang Bio, Inc. - Common Stock, $0.0001 Par Value (MBIO) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,033,145 shares. The largest 10 holders included ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, BlackRock Inc., Koss-Olinger Consulting, LLC, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, RENAISSANCE TECHNOLOGIES LLC, HighTower Advisors, LLC, NORTHERN TRUST CORP, and STATE STREET CORP. This page lists 25 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.